Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 04, 2019
CMAB Biopharma and Kintor announced a comprehensive strategic cooperation agreement for the development and manufacturing of ALK-1 monoclonal antibody (mAb).
read more
Thursday, February 18, 2016
CMC Biologics A/S and IDT Biologika GmbH have announced the formation of a strategic collaboration to provide a complete and efficient solution for the manufacture of antibody drug conjugates (ADCs).
read more
CMC Biologics, Inc., a global leader in process development and contract
manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company
focused on discovering and developing innovative monoclonal antibody-based ...
read more
CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based ...
read more
Friday, December 20, 2013
CMC Biologics and OncoSynergy announced today that the two
companies entered into an agreement for cell-line development, process development,
analytical development and manufacturing of non-GMP material to enable early toxicology
testing and cGMP...
read more
Tuesday, December 29, 2015
CMC Biologics, Inc. today announced that they have entered into an agreement with Immunocore Limited, a leading UK-based biotechnology company focused on developing new treatments for cancer, viral infections and autoimmune diseases, for the process ...
read more
CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture, today announced that it has hired Patricio E. Massera to serve as the Company’s new General Manager for its ...
read more
CMC Biologics, Inc., a global leader in process development and contract manufacturing, today announced that it has entered in to a Commercial Supply Agreement with Portola Pharmaceuticals, a biopharmaceutical company for the development of andexanet...
read more
CMC ICOS Biologics and Trellis Bioscience have entered into a manufacturing agreement for the process development and production of two of Trellis’ monoclonal antibodies.
read more
Tuesday, December 12, 2017
CMC ICOS Biologics and Harpoon Therapeutics have entered into an agreement for the development and manufacturing of HPN424, HPN536, and HPN217.
read more
Monday, December 12, 2022
Solon, OH: CMC Pharmaceuticals has been awarded a Sequential Phase II Small Business Innovation Research (“SBIR”) grant from the U.S. Defense Department’s (“DoD”) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear ...
read more
Thursday, August 31, 2017
Cmed announced its one-year anniversary of the launch of encapsia, its cloud-based clinical data suite of Apps that helps biotech and pharma sponsors manage the way data is captured, monitored and reviewed in clinical trials.
read more
Cmed Clinical Services, an eClinical technology-led CRO, announced today the appointment of Graham Belgrave as Chief Operations Officer.
read more
AIXIAL, the CRO of ALTEN Group, has announced the acquisition of UK headquartered CMED Group by ALTEN EUROPE.
read more
Cmed has announced it will present its encapsia clinical data suite at Mobile in Clinical Trials and DPharm: Disruptive Innovations to Advance Clinical Trials 2017.
read more